Other Markets Targeted by ASAC Enabled Applications
Absorbed Natural Gas Storage
As of January 2017, there are over 23 million of Natural Gas Vehicle worldwide. Currently, most NGVs use either CNG (Compressed Natural Gas) or LNG (Liquid Natural Gas) techniques to store natural gas. However, those storage methods require either high pressures (over 3000 psig) or low temperatures (-160℃) which increased the natural gas fueling stations infrastructure cost and also posed rigid requirements for the storage cylinder materials. Absorptive Natural Gas(ANG) is a novel storage method that use activated carbons to store natural gas, which operates in low pressure (500~1000 psig) and ambient temperatures, leading to significant infrastructure cost savings (up to 50%) and flexible design options compared with CNGs.
Chronic Kidney Disease Medication
Chronic Kidney Disease (CKD) affects 15.1% of the world population. Approximately 3% suffers from medium to severe CKDs (Stage 3 to 5) that endangers their lives and requires immediate clinical treatments. Activated carbon has been developed as a medicine to treat CKDs by absorbing indole, a precursor of indoxyl sulfate (an elevated uremic toxin which contributes to the progression of CKDs). Medications made of high performance activated carbons have been approved and introduced to the market in Japan, Korea and the Philippines, and are undergoing Phase III evaluation in North America/Latin America and Europe.